Clinical Trial Update: A Phase 1, Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 trial evaluating the safety and tolerability of ALV003 in healthy adult volunteers and in individuals with well-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• ALV003

Snippet

Sponsor: Alvine Pharmaceuticals Inc. | Conditions: Celiac Disease | Phase 1 | Status: COMPLETED